English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/81432
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Constitutive/hypoxic degradation of HIF-α proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein

AuthorsÁlvarez-Castelao, Beatriz; Castaño, José G.; Caro, Jaime
Issue Date2007
PublisherAmerican Society for Biochemistry and Molecular Biology
CitationJournal of Biological Chemistry 282(21): 15498-15505 (2007)
AbstractThe transcriptional activator complex HIF-1 plays a key role in the long term adaptation of cells and tissues to their hypoxic microenvironment by stimulating the expression of genes involved in angiogenesis and glycolysis. The expression of the HIF-1 complex is regulated by the levels of its HIF-α subunits that are degraded under normoxic conditions by the ubiquitin-proteasome system. Whereas this pathway of HIF-α protein degradation has been well characterized, little is known of their turnover during prolonged hypoxic conditions. Herein, we describe a pathway by which HIF-1α and HIF-2α proteins are constitutively degraded during hypoxia by the proteasome system, although without requirement of prior ubiquitylation. The constitutive/hypoxic degradation of HIF-α proteins is independent of the presence of VHL, binding to DNA, or the formation of a transcriptionally active HIF-1 complex. These results are further strengthened by the demonstration that HIF-α proteins are directly degraded in a reconstituted in vitro assay by the proteasome. Finally, we demonstrate that the persistent downregulation of HIF-1α during prolonged hypoxia is mainly caused by a decreased production of the protein without change in its degradation rate. This constitutive, ubiquitin-independent proteasomal degradation pathway of HIF-α proteins has to be taken into account in understanding the biology as well as in the development of therapeutic interventions of highly hypoxic tumors. © 2007 by The American Society for Biochemistry and Molecular Biology, Inc.
URIhttp://hdl.handle.net/10261/81432
DOI10.1074/jbc.M700704200
Identifiersdoi: 10.1074/jbc.M700704200
issn: 0021-9258
e-issn: 1083-351X
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.